Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(4.05)
# 500
Out of 5,163 analysts
336
Total ratings
42.26%
Success rate
15.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $48.75 | +64.10% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $63.66 | +17.81% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $71.19 | -8.70% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $24.81 | -43.57% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $12.80 | +681.25% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $40.00 | +12.50% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $18.75 | +300.00% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $36.22 | -17.17% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $16.12 | +172.95% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $16.40 | -39.02% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $21.25 | -52.94% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $12.76 | +135.11% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $8.26 | +1,413.32% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $15.80 | -5.06% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.12 | +348.43% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.95 | -44.13% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.68 | +6.84% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $6.66 | +125.23% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $21.51 | +109.21% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.44 | +22.95% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.39 | +441.27% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.36 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.46 | +379.45% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $6.17 | -51.38% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.34 | -14.53% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.32 | +581.82% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.76 | +215.13% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36,160,000 → $13,786,000 | $1.82 | +757,472,427.47% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.93 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $48.75
Upside: +64.10%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $63.66
Upside: +17.81%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $71.19
Upside: -8.70%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $24.81
Upside: -43.57%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $12.80
Upside: +681.25%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $40.00
Upside: +12.50%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $18.75
Upside: +300.00%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $36.22
Upside: -17.17%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $16.12
Upside: +172.95%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $16.40
Upside: -39.02%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $21.25
Upside: -52.94%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $12.76
Upside: +135.11%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $8.26
Upside: +1,413.32%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $15.80
Upside: -5.06%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.12
Upside: +348.43%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.95
Upside: -44.13%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.68
Upside: +6.84%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $6.66
Upside: +125.23%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.51
Upside: +109.21%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.44
Upside: +22.95%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.39
Upside: +441.27%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $9.36
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.46
Upside: +379.45%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $6.17
Upside: -51.38%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.34
Upside: -14.53%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.32
Upside: +581.82%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.76
Upside: +215.13%
Sep 6, 2023
Maintains: Buy
Price Target: $36,160,000 → $13,786,000
Current: $1.82
Upside: +757,472,427.47%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.93
Upside: -